CONCLUSIONS
We conclude, from our results, that the use of BIMA in coronary
revascularization offers a long-term survival benefit compared to SIMA,
and that the use of BIMA does not increase the rate of postoperative
complications, including deep sternal wound infection.
Excellent outcome can be achieved with OPCAB BIMA in real world practice
with adequate patient selection.